Medtronic Defeats Investor Suit Claiming Insulin Pump Deception

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said.

The latest version of the complaint “suffers from the same deficiencies” as one dismissed by the previous judge in the case, Judge Laura M. Provinzino said Tuesday for the US District Court for the District of Minnesota. She dismissed the suit with finality.

• The investors alleged Medtronic and its top executives schemed to conceal quality issues with the pumps and then misled investors about their interactions with the Food and Drug Administration and the progress of ...